L. Weißbach

7.2k total citations · 1 hit paper
232 papers, 3.7k citations indexed

About

L. Weißbach is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, L. Weißbach has authored 232 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Surgery, 90 papers in Pulmonary and Respiratory Medicine and 33 papers in Molecular Biology. Recurrent topics in L. Weißbach's work include Testicular diseases and treatments (91 papers), Prostate Cancer Treatment and Research (54 papers) and Prostate Cancer Diagnosis and Treatment (50 papers). L. Weißbach is often cited by papers focused on Testicular diseases and treatments (91 papers), Prostate Cancer Treatment and Research (54 papers) and Prostate Cancer Diagnosis and Treatment (50 papers). L. Weißbach collaborates with scholars based in Germany, United States and Poland. L. Weißbach's co-authors include Axel Heidenreich, Sabine Kliesch, Peter Albers, Michael Hartmann, S. Krege, R. Bußar-Maatz, J. Hartlapp, Manfred P. Wirth, Kurt Miller and Axel Hinke and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

L. Weißbach

199 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

2009 596 citations L. Weißbach et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Weißbach Germany	27	2.2k	1.7k	838	786	764	232	3.7k
Jeremy Sturgeon Canada	32	2.0k 0.9×	751 0.4×	662 0.8×	626 0.8×	936 1.2×	79	3.1k
Eva Cavallin‐Ståhl Sweden	39	1.6k 0.7×	1.0k 0.6×	398 0.5×	817 1.0×	665 0.9×	119	4.6k
Gillian Thomas Canada	45	2.8k 1.3×	1.2k 0.7×	380 0.5×	475 0.6×	1.6k 2.1×	134	5.9k
Gabriella Cohn‐Cedermark Sweden	22	2.0k 0.9×	694 0.4×	774 0.9×	771 1.0×	670 0.9×	61	2.7k
Howard S. Levin United States	37	1.4k 0.7×	2.0k 1.2×	588 0.7×	667 0.8×	212 0.3×	90	3.5k
Graham M. Mead United Kingdom	38	3.7k 1.7×	1.2k 0.7×	712 0.8×	871 1.1×	873 1.1×	140	5.6k
Melvin L. Samuels United States	28	1.5k 0.7×	1.1k 0.7×	305 0.4×	483 0.6×	346 0.5×	44	2.5k
Frederick B. Ruymann United States	32	890 0.4×	2.4k 1.4×	868 1.0×	627 0.8×	129 0.2×	78	4.7k
H.W. Herr United States	36	3.7k 1.7×	1.1k 0.6×	609 0.7×	895 1.1×	396 0.5×	82	4.4k
M.H. Cullen United Kingdom	23	933 0.4×	936 0.6×	329 0.4×	427 0.5×	282 0.4×	61	2.6k

Countries citing papers authored by L. Weißbach

Since Specialization

Citations

This map shows the geographic impact of L. Weißbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Weißbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Weißbach more than expected).

Fields of papers citing papers by L. Weißbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Weißbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Weißbach. The network helps show where L. Weißbach may publish in the future.

Co-authorship network of co-authors of L. Weißbach

This figure shows the co-authorship network connecting the top 25 collaborators of L. Weißbach. A scholar is included among the top collaborators of L. Weißbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Weißbach. L. Weißbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamm, Charlie Alexander, Patrick Asbach, Ivo G. Schoots, et al.. (2024). Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer. JAMA Oncology. 11(2). 145–145. 2 indexed citations

Herden, Jan, et al.. (2021). Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study. Urologia Internationalis. 105(5-6). 428–435. 8 indexed citations

Herden, Jan, Axel Heidenreich, Christian Wittekind, & L. Weißbach. (2018). Predictive value of the UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classification for patients treated with radical prostatectomy. Cancer Epidemiology. 56. 126–132. 3 indexed citations

Honecker, Friedemann, et al.. (2018). Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study. Journal of Cancer Research and Clinical Oncology. 144(3). 571–577. 18 indexed citations

Baur, Alexander, Thomas Henkel, Manfred Johannsen, et al.. (2017). A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study. Contemporary Clinical Trials. 56. 46–51. 1 indexed citations

Herden, Jan, Axel Heidenreich, & L. Weißbach. (2016). TNM-Klassifikation des lokalisierten Prostatakarzinoms: Die cT-Kategorie entspricht nicht ihren klinischen Erfordernissen. Urologe A. 55(12). 1564–1572.

Chun, Felix K.‐H., Andreas Becker, Luis A. Kluth, et al.. (2014). Die Versorgung von Patienten mit lokal begrenztem Prostatakarzinom in Deutschland. Der Urologe. 54(1). 6–13.

Weißbach, L., et al.. (2010). Aktuelles: HAROW: Versorgungsforschung bei Patienten mit lokal begrenztem Prostatakarzinom. Journal für Kardiologie (Krause & Pachernegg GmbH). 8(1). 41–42.

Weißbach, L. & Jens E. Altwein. (2009). Active Surveillance or Active Treatment in Localized Prostate Cancer?. Deutsches Ärzteblatt international. 106(22). 371–6. 17 indexed citations

10.

Schubert-Fritschle, G., L. Weißbach, & D. Hölzel. (2005). Nachsorge oder keine Nachsorge — das ist hier die Frage!. Der Urologe. 44(9). 991–996. 1 indexed citations

11.

Weißbach, L. & Felix Sedlmayer. (2004). Einschätzung des PSA-Rezidivs nach kurativer Therapie des Prostatakarzinoms. Journal für Kardiologie (Krause & Pachernegg GmbH). 11(3). 3–11. 2 indexed citations

12.

Kristiansen, Glen, Christian Pilarsky, Christoph Wissmann, et al.. (2002). ALCAM/CD166 is up‐regulated in low‐grade prostate cancer and progressively lost in high‐grade lesions. The Prostate. 54(1). 34–43. 118 indexed citations

13.

Weißbach, L., et al.. (1998). Stone formation after pyeloplasty through the suture material. Der Urologe. 37(5). 522–525. 4 indexed citations

14.

Räth, U., B.K. Upadhyaya, Hannes Böckmann, et al.. (1993). Role of Ondansetron plus Dexamethasone in Fractionated Chemotherapy. Oncology. 50(3). 168–172. 23 indexed citations

15.

Göbel, U., M. Bamberg, Rainer Haas, et al.. (1989). Nichttestikuläre Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 247–260. 4 indexed citations

16.

Schweikert, Hans‐Udo, et al.. (1987). Clinical and Endocrinological Characterization of Two Subjects with Reifenstein Syndrome Associated with Qualitative Abnormalities of the Androgen Receptor. Hormone Research. 25(2). 72–79. 9 indexed citations

17.

Weißbach, L., et al.. (1985). Techniques of retroperitoneal lymph node dissection.. PubMed. 53(2). 318–40. 1 indexed citations

18.

Bojar, Hans, L. Weißbach, D. Petzinna, Kitti Maár, & W. Staib. (1985). Steroid Receptor Status of Human Testicular Tumors. Urologia Internationalis. 40(3). 160–163. 3 indexed citations

19.

Fritz, Klaus & L. Weißbach. (1985). Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fertility and Sterility. 43(3). 451–454. 33 indexed citations

20.

Weißbach, L., et al.. (1976). [Sisomicin treatment of urinary tract infections (author's transl)].. PubMed. 71(32-33). 1300–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact